Genetic Tech up 55% on move into COVID-19 testing
Apr. 17, 2020 8:04 AMGenetic Technologies Limited (GENE)By: Douglas W. House, SA News Editor
Thinly traded nano cap Genetic Technologies Limited (NASDAQ:GENE) jumps 55% premarket on robust volume in apparent reaction to its "temporary" transition into high-throughput COVID-19 testing (cited on social media). The company can, supposedly, perform ~360K tests per year with the potential to double the output.